212832-16-1

Basic information

• Product Name: 1-Piperazinepropanamine, N,N-bis(4-fluorophenyl)-
• CAS NO: 212832-16-1
• Molecular Formula: C19H23F2N3
• Molecular Weight: 331.409
• Mol File: 212832-16-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-Piperazinepropanamine, N,N-bis(4-fluorophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperazinepropanamine, N,N-bis(4-fluorophenyl)-(212832-16-1)
• EPA Substance Registry System: 1-Piperazinepropanamine, N,N-bis(4-fluorophenyl)-(212832-16-1)

Safety Data

• Hazardous Substances Data: 212832-16-1(Hazardous Substances Data)

Upstream product

• 95017-63-3 3-bromo-N,N-bis(4-fluorophenyl)propanamide 
• 330-91-6 bis-(4-fluoro-phenyl)-amine 

Downstream Products

• 815608-49-2 3-[4-(4-nitrobenzyl)-1-piperazinyl]propyl-N,N-bis(4-fluorophenyl)amine 
• 569353-92-0 1-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-3-phenylpropan-3-ol 
• 815608-51-6 bis-(4-fluoro-phenyl)-(3-{4-[2-(4-nitro-phenyl)-ethyl]-piperazin-1-yl}-propyl)-amine 
• 569681-70-5 1-[3-[N,N-bis(4-fluorophenyl)amino]propyl]-4-[3-[(N-ethoxycarbonyl-N-phenyl)amino]-2-hydroxypropyl]piperazine 
• 1027589-19-0 (4-{3-[bis-(4-fluoro-phenyl)-amino]-propyl}-piperazin-1-yl)-phenyl-methanone 
• 1027206-55-8 3-(4-{3-[bis-(4-fluoro-phenyl)-amino]-propyl}-piperazin-1-yl)-1-phenyl-propan-1-one 
• 815608-62-9 3-[4-(3-iodo-4-aminophenylethyl)-1-piperazinyl]propyl-N,N-bis(4-fluorophenyl)amine 
• 815608-60-7 3-[4-(3-iodo-4-aminobenzyl)-1-piperazinyl]propyl-N,N-bis(4-fluorophenyl)amine 
• 815608-54-9 3-[4-(4-aminophenylethyl)-1-piperazinyl]propyl-N,N-bis(4-fluorophenyl)amine 
• 815608-52-7 3-[4-(4-aminobenzyl)-1-piperazinyl]propyl-N,N-bis(4-fluorophenyl)amine 

Relevant articles and documents

Dual probes for the dopamine transporter and σ1 receptors: Novel piperazinyl alkyl-bis(4′-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents

Both dopamine uptake inhibitors and σ1 receptor antagonists have been implicated as potential pharmacotherapeutics for the treatment of cocaine abuse. While the dopamine uptake inhibitors may share with cocaine neurochemical mechanisms underlyi